Ventrus Biosciences Announces Closing of Initial Public Offering of Common Stock
December 23, 2010 08:00 ET
|
Ventrus Biosciences
NEW YORK, Dec. 23, 2010 (GLOBE NEWSWIRE) -- Ventrus Biosciences Inc. ("Ventrus") (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today...
Ventrus Biosciences Announces Pricing of Its Initial Public Offering
December 16, 2010 21:00 ET
|
Ventrus Biosciences
NEW YORK, Dec. 16, 2010 (GLOBE NEWSWIRE) -- Ventrus Biosciences Inc. ("Ventrus") (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today...